| 注册
首页|期刊导航|中国药理学通报|COX-2抑制剂联合抗肿瘤的研究进展

COX-2抑制剂联合抗肿瘤的研究进展

刘智豪 刘叔文 余乐

中国药理学通报2012,Vol.28Issue(12):1651-1654,4.
中国药理学通报2012,Vol.28Issue(12):1651-1654,4.DOI:10.3969/j.issn.1001-1978.2012.12.006

COX-2抑制剂联合抗肿瘤的研究进展

Antitumor effects of COX-2 inhibitors in combination therapy

刘智豪 1刘叔文 2余乐2

作者信息

  • 1. 南方医科大学第一临床医学院,广东,广州,510515
  • 2. 南方医科大学药学院,广东,广州,510515
  • 折叠

摘要

Abstract

There is convincing epidemiological and experimental evidence demonstrating that COX-2 selective inhibitors show chemoprophylactic and chemotherapeutic potential in various tumors. Moreover, COX-2 selective inhibitors are able to influence the cytotoxicity of chemotherapeutic drugs. In this regard, COX-2 selective inhibitors in combination with chemotherapeutic drugs may present a new therapeutic strategy. The present review intends to focus on the experimental and clinical studies on COX-2 selective inhibitors in combination with chemotherapeutic drugs, analyzing the controversial results from different studies and exploring the possible related mechanisms.

关键词

COX-2抑制剂/联合疗法/肿瘤/临床研究/体外研究/化疗

Key words

COX-2 inhibitor/ combination therapy/ cancer/clinical research/ in vitro/ chemotherapy

分类

医药卫生

引用本文复制引用

刘智豪,刘叔文,余乐..COX-2抑制剂联合抗肿瘤的研究进展[J].中国药理学通报,2012,28(12):1651-1654,4.

基金项目

国家自然科学基金资助项目(No 81001456) (No 81001456)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量6
|
下载量0
段落导航相关论文